Is Elon's Empire Crumbling?

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Meet Amy Gleason, the DOGE administrator who may - or may not - be wielding extraordinary power

RYAN J. FOLEY and BRIAN SLODYSKO
March 08, 2025

When her daughter was diagnosed with a rare autoimmune disease in 2010, Amy Gleason attacked the challenge.

She carried binders of medical records to doctors' appointments across six health systems seeking the best care for juvenile dermatomyositis. She volunteered at a nonprofit searching for a cure. She also started a health care company to create record-sharing software that would make life easier for chronically ill patients and families.

Within five years, President Barack Obama's White House recognized Gleason as a "Champion of Change" in the industry. When the coronavirus struck in 2020, she was a health care technologist in the first Trump White House who worked grueling hours building data systems to guide the federal response. (And her daughter was a thriving college student.)

Now, her journey has improbably led to President Donald Trump naming her the acting administrator of the U.S. DOGE Service, a position that seems to convey extraordinary power. Except almost no one has heard of her and everyone knows the man the president says is actually leading the unparalleled effort to gut the federal workforce and shutter agencies: Elon Musk.

Gleason's role at DOGE is unclear

While Musk has claimed his Department of Government Efficiency is fully transparent, until last week the White House press secretary would not even say Gleason's name -- which does not appear on the DOGE website.

In his address to Congress Tuesday, Trump made clear that Musk is in charge, saluting him as the head of DOGE, with Musk smiling down on the president from the visitors' gallery. Yet government lawyers have argued in court that Gleason and not Musk is the agency's leader.

The confusion has added to the mystery around the role of Gleason, who did not respond to a phone call or text message for comment.

"I don't think anyone really knows for sure what her role is and whether she actually has any oversight of any of the people doing the work, or is she just there as a punching bag and a distraction to keep their actual activities shielded from the public," said Brett Hartl, government affairs director for the Center for Biological Diversity, an environmental group that sued the DOGE Service and Gleason seeking access to records that would shed light on their operations.

DOGE claims credit for saving more than $100 billion through mass firings, cancellations of contracts and grants, office closures and other cuts that have paralyzed entire agencies. Many of those claimed savings have turned out to be overstated or unproven.

Gleason is known as a behind-the-scenes operator

On one level, Gleason fits the mold of a Musk employee, one willing to work arduous hours to meet his goals. Former colleagues say she is an effective behind-the-scenes operator and say her rise is the story of a former nurse who got into health care technology to help patients and doctors and climbed through merit.

"From my perspective, I can't imagine somebody I'd rather have there," said Jamie Grant, a former Republican lawmaker in Florida who worked with Gleason to start a health care company. "Somebody saying yes to that job right now better believe in the mission and better have a spine and be talented and she's that in spades."

White House press secretary Karoline Leavitt told reporters that Gleason had served as the acting administrator at DOGE for weeks. But that was not the widely held understanding of her position internally, according to three people with knowledge of the office's operation who spoke on condition of anonymity out of fear of retribution.

While the exact nature of Gleason's portfolio was not well defined, what was clear is that she was working closely with DOGE leaders. She attempted to push civil service staffers in the office to hire at least two people who failed screening reviews for prospective hires; both were later hired by DOGE, according to two of the people who spoke to The Associated Press.

The uncertainty over her role -- and when she was appointed to it -- could have far-reaching implications in a series of ongoing lawsuits filed to blunt the impact of Musk's radical paring of the government workforce.

Under questioning from U.S. District Court Judge Colleen Kollar-Kotelly recently, government attorneys struggled to explain who was in charge of DOGE or Musk's precise role. That led Kollar-Kotelly to wonder if the office was running afoul of the Constitution's appointments clause because Musk had not been nominated to lead the office, or received confirmation from the Senate.

The Trump administration announced the following day that Gleason was DOGE's acting administrator, a question they had previously refused to answer.

Gleason has ties to Trump world

Unlike many DOGE workers, Gleason has no prior ties to Musk. She recently worked as chief products officer at Nashville-based health care firms founded by Brad Smith, who worked in the prior Trump administration on health care and is also a DOGE adviser.

Smith and Gleason began working on Trump's transition after the November election, and her role in Trump's orbit has grown. In December, she rejoined the United States Digital Service, where she had previously worked from 2018 through 2021 on high-level government health care technology initiatives.

On his first day back in office, Trump signed an executive order rebranding USDS as the US DOGE Service and giving it a mandate to help Musk's cost-cutting initiative. Soon, dozens of Musk acolytes associated with DOGE began arriving at agencies across the government demanding access to sensitive data systems and pushing for drastic changes.

While 21 others in the office resigned in protest rather than carry out Musk's initiatives, Gleason accepted a position that thrust her into an unfamiliar spotlight.

Health care entrepreneur Travis Bond, Gleason's colleague over two decades at companies in Florida, said Gleason will hate the public attention but excel in her new role.

"I'm not sure they could have picked a better person. She just thinks, eats and breathes this stuff," he said.

Gleason helped build CareSync, which later collapsed

Bond, Gleason and Grant in 2011 launched CareSync Inc., which developed an app to allow patients suffering from chronic disease to keep their medical records in one place. After benefiting from a $7.25 million grant from one Florida county, CareSync found it hard to attract buyers for subscriptions that cost up to $199 annually.

CareSync pivoted in 2015, taking advantage of a new federal rule that allowed Medicare providers to bill for chronic care management services delivered remotely. The company raised millions of dollars from investors and began rapidly adding staff and serving more than 20,000 patients nationwide. By summer 2018, CareSync ran out of cash and closed without notice, firing 300 workers and leaving creditors owed millions.

Gleason recalled later that she was "trying to figure out what in the world to do in life" after that experience and applied for the USDS with encouragement from Aneesh Chopra, U.S. chief technology officer under Obama. Chopra declined comment.

She focused on improving technology systems at the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services. During the pandemic, she worked under White House response coordinator Dr. Deborah Birx to develop laboratory and hospital data reporting systems. Birx praised Gleason last week in an interview with CNN as a "really competent, hardworking, focused woman who understands the value of data."

Near the end of her three-year stint in 2021, Gleason reflected on her work in a podcast interview, saying the digital service sought to "empower the civil servants and to bring new approaches in technology to the government and to help modernize their efforts."

"Our mission is really to do the greatest good, for the greatest number of people, in the greatest need," she said.

Continue Reading...

Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Tariff-Driven Cash Payouts, Right Off Your Smart Phone? - Ad

The U.S. Treasury has raked in $15B from Trump's tariffs - and now, thanks to Title 15, you could pocket $100-$1,000 upfront payouts yourself. No stocks needed. Just use your phone and my #1 income strategy to start collecting now.

BigBear.ai, AMD, QuantumScape, Coinbase, Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks ended the day on a high note, with the Nasdaq gaining over 1.4% on Tuesday to 19,912.53. The Dow also traded up 1.2% to 43,089.02, while the S&P 500 rose by 1.1% to 6,092.18. These are the top stocks that gained the attention of retail traders and investors throughout the day:

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Alibaba Cloud Opens Third Malaysia Data Center, Plans Second in Philippines

Alibaba expands cloud networks and AI capabilities globally, opening new data centers in Malaysia, Philippines, and South Korea by 2025.

U.S. employers likely added 115,000 jobs last month as labor market continues to cool

The steady slowdown in U.S. hiring likely continued in June as President Donald Trump’s trade wars, federal hiring freeze and immigration crackdown weighed on the American job market.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

German court suspends diesel scandal trial of former Volkswagen CEO Winterkorn

FRANKFURT, Germany (AP) — A German court has suspended proceedings of former Volkswagen CEO Martin Winterkorn, who has been charged with fraud and market manipulation in connection with the automaker's use of rigged software that let millions of diesel-engine cars cheat on emissions tests.

Cuban's AI Prediction, IBM's Rise, Musk's New Hire And More: This Week In AI

Top stories on AI, including Cuban predicting a trillionaire, IBM's success, Musk's xAI hire, and debates on AI's impact on employment.

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

Latest 'Tiger King' twist finds 'Doc' Antle facing possible prison sentence for animal trafficking

Five years after the true crime documentary “Tiger King” captivated a country shut down by COVID-19, the for one of its main characters will be resolved Tuesday in a courtroom in South Carolina.

Cramer Praises Monster Beverage As 'Smoking Hot,' Warns Investors About This AI Stock

Cramer recommends buying Okta (OKTA) as it reported strong earnings, but not to trust Nebius Group (NBIS), while Sweetgreen (SG) and Monster Beverage (MNST) have mixed views. He also suggests buying McDonald's (MCD) while their partnership with Krispy Kreme (DNUT) will end in 2025.

Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad

The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.

US-Iran Nuclear Deal In 2025? Crypto Bettors On Polymarket See Strong Chance After Trump's Ceasefire Announcement

Cryptocurrency bettors sharply raised their odds on Monday that the United States and Iran would strike a nuclear deal in 2025 after President Donald Trump confirmed a ceasefire in the ongoing Middle East conflict.

Home Depot's $5.5B Deal Expands Its Reach To Thousands Of Job Sites

Analyst maintains Buy rating on Home Depot with $450 price target, noting plans for subsidiary SRS Distribution to acquire GMS for $4.3B.

Do These 4 Things to Your Bank Account Now ... - Ad

A sweeping U.S. policy could soon let the government track-or even freeze-your bank account. But there are 4 simple steps you can take right now to protect your savings before it's potentially too late.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.

Scott Bessent On Replacing Powell As Fed Chair: 'I Will Do What The President Wants' — Plays Down Shadow Chair Speculations

U.S. Treasury Secretary Scott Bessent declined to rule out the possibility of replacing Jerome Powell as Federal Reserve Chair and has instead deferred to President Donald Trump's decision on the matter.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

President Trump announces trade deal with Vietnam that will let US goods into the country duty-free

WASHINGTON (AP) — President Donald Trump announced a trade deal with Vietnam Wednesday that would allow U.S. goods to enter the country duty-free.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Trump's Sweeping Tax Bill, Tariff Hikes, Gavin Newsom's Tour And More: This Week In Politics

The past week was full of political activity as Trump signed the tax bill. Newsom sparked rumors with a South Carolina tour.

Cash-Rich IonQ To Capture 20% Of Quantum Market By 2035

IonQ shares climb as investors rally behind its bold quantum growth strategy and long-term market potential.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Quantum Stocks Surge And Stumble: Here's What Happened This Week

Quantum Computing announced a $200 million private placement, Microsoft's CEO said quantum computing could take scientific advancements to the next level and more from the week.

Google's AI Overviews Features Sparks New Antitrust Battle With European Publishers: Report

An antitrust complaint was filed by a group of independent publishers from European Union against Google, alleging misuse of its AI Overviews.

Tariff-Driven Cash Payouts, Right Off Your Smart Phone? - Ad

The U.S. Treasury has raked in $15B from Trump's tariffs - and now, thanks to Title 15, you could pocket $100-$1,000 upfront payouts yourself. No stocks needed. Just use your phone and my #1 income strategy to start collecting now.

Bitcoin Gets 'Bigger' The More Money Central Banks Print, Says Popular Crypto Analyst: 'It's A Beautiful Thing'

Bitcoin (CRYPTO: BTC) purist Willy Woo tied the leading cryptocurrency’s growth with global liquidity on Wednesday, stating that the more money printed, the larger it will become.

How to manage ADHD at work and turn it into a strength

NEW YORK (AP) — Jeremy Didier had taken her son to a psychologist for a when she spotted an article about women with the condition. As she read it in the waiting room, she thought to herself: They're describing me.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Energy ETFs In Focus After Exxon Flags $1.5 Billion Profit Hit

Exxon's caution pressures energy ETFs like XLE and VDE, as oil prices dip and investors weigh OPEC+ moves and sector rotation risks.

Elon Musk Says 'Clear Path' To Restoring Hearing With Neuralink, But The Deaf Community Want To Have Their 'Say'

Elon Musk's Neuralink faces backlash from the deaf community after proposing brain implant technology to restore hearing, with deaf adults calling for inclusion in the research process.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Ex-Obama Treasury Secretary Jack Lew Sounds Alarm On NYC Under Zohran Mamdani: 'I Worry Deeply'

With Zohran Mamdani officially securing the Democratic nomination in the New York City mayoral race, centrist figures within the Democratic party, such as former Treasury Secretary Jack Lew, are raising questions on the city's future under a self-described Democratic Socialist.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service